nodes	percent_of_prediction	percent_of_DWPC	metapath
Omeprazole—kidney cancer—Dexamethasone—multiple sclerosis	0.156	0.29	CpDpCtD
Omeprazole—kidney cancer—Betamethasone—multiple sclerosis	0.156	0.29	CpDpCtD
Omeprazole—prostate cancer—Betamethasone—multiple sclerosis	0.113	0.21	CpDpCtD
Omeprazole—prostate cancer—Dexamethasone—multiple sclerosis	0.113	0.21	CpDpCtD
Omeprazole—CYP1B1—Mitoxantrone—multiple sclerosis	0.0444	0.133	CbGbCtD
Omeprazole—CYP11A1—Dexamethasone—multiple sclerosis	0.0401	0.12	CbGbCtD
Omeprazole—ABCG2—Cladribine—multiple sclerosis	0.0289	0.0864	CbGbCtD
Omeprazole—CYP1B1—Dexamethasone—multiple sclerosis	0.023	0.0687	CbGbCtD
Omeprazole—ABCC3—Methotrexate—multiple sclerosis	0.0214	0.0639	CbGbCtD
Omeprazole—ABCG2—Mitoxantrone—multiple sclerosis	0.0211	0.063	CbGbCtD
Omeprazole—CYP2D6—Fingolimod—multiple sclerosis	0.0153	0.0456	CbGbCtD
Omeprazole—ABCG2—Dexamethasone—multiple sclerosis	0.0109	0.0327	CbGbCtD
Omeprazole—ABCB1—Methylprednisolone—multiple sclerosis	0.0104	0.0312	CbGbCtD
Omeprazole—CYP1A1—Dexamethasone—multiple sclerosis	0.0101	0.0302	CbGbCtD
Omeprazole—CYP3A4—Fingolimod—multiple sclerosis	0.0097	0.029	CbGbCtD
Omeprazole—ABCG2—Methotrexate—multiple sclerosis	0.00879	0.0263	CbGbCtD
Omeprazole—CYP2C19—Prednisone—multiple sclerosis	0.00783	0.0234	CbGbCtD
Omeprazole—ABCB1—Mitoxantrone—multiple sclerosis	0.00761	0.0227	CbGbCtD
Omeprazole—ABCB1—Betamethasone—multiple sclerosis	0.00678	0.0203	CbGbCtD
Omeprazole—ABCB1—Prednisolone—multiple sclerosis	0.00669	0.02	CbGbCtD
Omeprazole—ABCB1—Prednisone—multiple sclerosis	0.00632	0.0189	CbGbCtD
Omeprazole—CYP3A4—Methylprednisolone—multiple sclerosis	0.00625	0.0187	CbGbCtD
Omeprazole—CYP2C8—Dexamethasone—multiple sclerosis	0.00583	0.0174	CbGbCtD
Omeprazole—CYP2C19—Dexamethasone—multiple sclerosis	0.00489	0.0146	CbGbCtD
Omeprazole—CYP3A4—Triamcinolone—multiple sclerosis	0.00474	0.0141	CbGbCtD
Omeprazole—CYP3A4—Mitoxantrone—multiple sclerosis	0.00456	0.0136	CbGbCtD
Omeprazole—CYP2C9—Dexamethasone—multiple sclerosis	0.00407	0.0121	CbGbCtD
Omeprazole—CYP3A4—Betamethasone—multiple sclerosis	0.00406	0.0121	CbGbCtD
Omeprazole—CYP3A4—Prednisolone—multiple sclerosis	0.00401	0.012	CbGbCtD
Omeprazole—ABCB1—Dexamethasone—multiple sclerosis	0.00395	0.0118	CbGbCtD
Omeprazole—CYP3A4—Prednisone—multiple sclerosis	0.00379	0.0113	CbGbCtD
Omeprazole—CYP2D6—Dexamethasone—multiple sclerosis	0.00372	0.0111	CbGbCtD
Omeprazole—ABCB1—Methotrexate—multiple sclerosis	0.00317	0.00947	CbGbCtD
Omeprazole—CYP3A4—Dexamethasone—multiple sclerosis	0.00236	0.00706	CbGbCtD
Omeprazole—Vertigo—Betamethasone—multiple sclerosis	5.84e-05	0.00062	CcSEcCtD
Omeprazole—Vertigo—Dexamethasone—multiple sclerosis	5.84e-05	0.00062	CcSEcCtD
Omeprazole—Anaphylactic shock—Methylprednisolone—multiple sclerosis	5.83e-05	0.000619	CcSEcCtD
Omeprazole—Infection—Triamcinolone—multiple sclerosis	5.8e-05	0.000617	CcSEcCtD
Omeprazole—Infection—Methylprednisolone—multiple sclerosis	5.79e-05	0.000615	CcSEcCtD
Omeprazole—Haematuria—Methotrexate—multiple sclerosis	5.77e-05	0.000613	CcSEcCtD
Omeprazole—Shock—Triamcinolone—multiple sclerosis	5.75e-05	0.000611	CcSEcCtD
Omeprazole—Insomnia—Prednisolone—multiple sclerosis	5.75e-05	0.000611	CcSEcCtD
Omeprazole—Alopecia—Prednisone—multiple sclerosis	5.74e-05	0.00061	CcSEcCtD
Omeprazole—Shock—Methylprednisolone—multiple sclerosis	5.74e-05	0.000609	CcSEcCtD
Omeprazole—Hepatobiliary disease—Methotrexate—multiple sclerosis	5.72e-05	0.000608	CcSEcCtD
Omeprazole—Nervous system disorder—Methylprednisolone—multiple sclerosis	5.72e-05	0.000607	CcSEcCtD
Omeprazole—Epistaxis—Methotrexate—multiple sclerosis	5.71e-05	0.000606	CcSEcCtD
Omeprazole—Hypersensitivity—Mitoxantrone—multiple sclerosis	5.71e-05	0.000606	CcSEcCtD
Omeprazole—Paraesthesia—Prednisolone—multiple sclerosis	5.71e-05	0.000606	CcSEcCtD
Omeprazole—Tachycardia—Triamcinolone—multiple sclerosis	5.7e-05	0.000606	CcSEcCtD
Omeprazole—Mental disorder—Prednisone—multiple sclerosis	5.69e-05	0.000605	CcSEcCtD
Omeprazole—Nausea—Azathioprine—multiple sclerosis	5.69e-05	0.000605	CcSEcCtD
Omeprazole—Tachycardia—Methylprednisolone—multiple sclerosis	5.69e-05	0.000605	CcSEcCtD
Omeprazole—Skin disorder—Methylprednisolone—multiple sclerosis	5.66e-05	0.000602	CcSEcCtD
Omeprazole—Malnutrition—Prednisone—multiple sclerosis	5.66e-05	0.000601	CcSEcCtD
Omeprazole—Hyperhidrosis—Triamcinolone—multiple sclerosis	5.65e-05	0.0006	CcSEcCtD
Omeprazole—Agranulocytosis—Methotrexate—multiple sclerosis	5.65e-05	0.0006	CcSEcCtD
Omeprazole—Hyperhidrosis—Methylprednisolone—multiple sclerosis	5.64e-05	0.000599	CcSEcCtD
Omeprazole—Hypertension—Dexamethasone—multiple sclerosis	5.61e-05	0.000596	CcSEcCtD
Omeprazole—Hypertension—Betamethasone—multiple sclerosis	5.61e-05	0.000596	CcSEcCtD
Omeprazole—Asthenia—Mitoxantrone—multiple sclerosis	5.56e-05	0.00059	CcSEcCtD
Omeprazole—Myalgia—Betamethasone—multiple sclerosis	5.53e-05	0.000588	CcSEcCtD
Omeprazole—Myalgia—Dexamethasone—multiple sclerosis	5.53e-05	0.000588	CcSEcCtD
Omeprazole—Anxiety—Dexamethasone—multiple sclerosis	5.51e-05	0.000586	CcSEcCtD
Omeprazole—Anxiety—Betamethasone—multiple sclerosis	5.51e-05	0.000586	CcSEcCtD
Omeprazole—Discomfort—Betamethasone—multiple sclerosis	5.46e-05	0.000581	CcSEcCtD
Omeprazole—Discomfort—Dexamethasone—multiple sclerosis	5.46e-05	0.000581	CcSEcCtD
Omeprazole—Pain—Prednisolone—multiple sclerosis	5.43e-05	0.000577	CcSEcCtD
Omeprazole—Hepatitis—Methotrexate—multiple sclerosis	5.43e-05	0.000577	CcSEcCtD
Omeprazole—Pharyngitis—Methotrexate—multiple sclerosis	5.39e-05	0.000573	CcSEcCtD
Omeprazole—Urinary tract disorder—Methotrexate—multiple sclerosis	5.36e-05	0.00057	CcSEcCtD
Omeprazole—Vision blurred—Prednisone—multiple sclerosis	5.33e-05	0.000566	CcSEcCtD
Omeprazole—Urethral disorder—Methotrexate—multiple sclerosis	5.32e-05	0.000566	CcSEcCtD
Omeprazole—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	5.32e-05	0.000566	CcSEcCtD
Omeprazole—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	5.31e-05	0.000564	CcSEcCtD
Omeprazole—Anaphylactic shock—Betamethasone—multiple sclerosis	5.3e-05	0.000563	CcSEcCtD
Omeprazole—Anaphylactic shock—Dexamethasone—multiple sclerosis	5.3e-05	0.000563	CcSEcCtD
Omeprazole—Diarrhoea—Mitoxantrone—multiple sclerosis	5.3e-05	0.000563	CcSEcCtD
Omeprazole—Insomnia—Triamcinolone—multiple sclerosis	5.28e-05	0.000561	CcSEcCtD
Omeprazole—Insomnia—Methylprednisolone—multiple sclerosis	5.27e-05	0.00056	CcSEcCtD
Omeprazole—Infection—Dexamethasone—multiple sclerosis	5.27e-05	0.00056	CcSEcCtD
Omeprazole—Infection—Betamethasone—multiple sclerosis	5.27e-05	0.00056	CcSEcCtD
Omeprazole—Ill-defined disorder—Prednisone—multiple sclerosis	5.25e-05	0.000558	CcSEcCtD
Omeprazole—Paraesthesia—Triamcinolone—multiple sclerosis	5.25e-05	0.000557	CcSEcCtD
Omeprazole—Feeling abnormal—Prednisolone—multiple sclerosis	5.24e-05	0.000556	CcSEcCtD
Omeprazole—Paraesthesia—Methylprednisolone—multiple sclerosis	5.24e-05	0.000556	CcSEcCtD
Omeprazole—Visual impairment—Methotrexate—multiple sclerosis	5.23e-05	0.000556	CcSEcCtD
Omeprazole—Anaemia—Prednisone—multiple sclerosis	5.23e-05	0.000556	CcSEcCtD
Omeprazole—Shock—Betamethasone—multiple sclerosis	5.22e-05	0.000554	CcSEcCtD
Omeprazole—Shock—Dexamethasone—multiple sclerosis	5.22e-05	0.000554	CcSEcCtD
Omeprazole—Dyspnoea—Triamcinolone—multiple sclerosis	5.21e-05	0.000553	CcSEcCtD
Omeprazole—Nervous system disorder—Dexamethasone—multiple sclerosis	5.2e-05	0.000552	CcSEcCtD
Omeprazole—Nervous system disorder—Betamethasone—multiple sclerosis	5.2e-05	0.000552	CcSEcCtD
Omeprazole—Agitation—Prednisone—multiple sclerosis	5.2e-05	0.000552	CcSEcCtD
Omeprazole—Thrombocytopenia—Dexamethasone—multiple sclerosis	5.19e-05	0.000551	CcSEcCtD
Omeprazole—Thrombocytopenia—Betamethasone—multiple sclerosis	5.19e-05	0.000551	CcSEcCtD
Omeprazole—Tachycardia—Dexamethasone—multiple sclerosis	5.17e-05	0.00055	CcSEcCtD
Omeprazole—Tachycardia—Betamethasone—multiple sclerosis	5.17e-05	0.00055	CcSEcCtD
Omeprazole—Angioedema—Prednisone—multiple sclerosis	5.17e-05	0.000549	CcSEcCtD
Omeprazole—Dyspepsia—Triamcinolone—multiple sclerosis	5.14e-05	0.000546	CcSEcCtD
Omeprazole—Erythema multiforme—Methotrexate—multiple sclerosis	5.14e-05	0.000546	CcSEcCtD
Omeprazole—Dyspepsia—Methylprednisolone—multiple sclerosis	5.13e-05	0.000545	CcSEcCtD
Omeprazole—Hyperhidrosis—Dexamethasone—multiple sclerosis	5.13e-05	0.000545	CcSEcCtD
Omeprazole—Hyperhidrosis—Betamethasone—multiple sclerosis	5.13e-05	0.000545	CcSEcCtD
Omeprazole—Malaise—Prednisone—multiple sclerosis	5.1e-05	0.000542	CcSEcCtD
Omeprazole—Vertigo—Prednisone—multiple sclerosis	5.08e-05	0.00054	CcSEcCtD
Omeprazole—Eye disorder—Methotrexate—multiple sclerosis	5.08e-05	0.000539	CcSEcCtD
Omeprazole—Tinnitus—Methotrexate—multiple sclerosis	5.06e-05	0.000538	CcSEcCtD
Omeprazole—Anorexia—Dexamethasone—multiple sclerosis	5.05e-05	0.000537	CcSEcCtD
Omeprazole—Anorexia—Betamethasone—multiple sclerosis	5.05e-05	0.000537	CcSEcCtD
Omeprazole—Urticaria—Prednisolone—multiple sclerosis	5.05e-05	0.000536	CcSEcCtD
Omeprazole—Fatigue—Triamcinolone—multiple sclerosis	5.04e-05	0.000535	CcSEcCtD
Omeprazole—Fatigue—Methylprednisolone—multiple sclerosis	5.03e-05	0.000534	CcSEcCtD
Omeprazole—Pain—Triamcinolone—multiple sclerosis	5e-05	0.000531	CcSEcCtD
Omeprazole—Vomiting—Mitoxantrone—multiple sclerosis	4.92e-05	0.000523	CcSEcCtD
Omeprazole—Immune system disorder—Methotrexate—multiple sclerosis	4.91e-05	0.000521	CcSEcCtD
Omeprazole—Mediastinal disorder—Methotrexate—multiple sclerosis	4.89e-05	0.00052	CcSEcCtD
Omeprazole—Hypertension—Prednisone—multiple sclerosis	4.88e-05	0.000519	CcSEcCtD
Omeprazole—Rash—Mitoxantrone—multiple sclerosis	4.88e-05	0.000519	CcSEcCtD
Omeprazole—Dermatitis—Mitoxantrone—multiple sclerosis	4.88e-05	0.000518	CcSEcCtD
Omeprazole—Chills—Methotrexate—multiple sclerosis	4.87e-05	0.000518	CcSEcCtD
Omeprazole—Headache—Mitoxantrone—multiple sclerosis	4.85e-05	0.000515	CcSEcCtD
Omeprazole—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	4.83e-05	0.000513	CcSEcCtD
Omeprazole—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	4.83e-05	0.000513	CcSEcCtD
Omeprazole—Myalgia—Prednisone—multiple sclerosis	4.82e-05	0.000512	CcSEcCtD
Omeprazole—Arthralgia—Prednisone—multiple sclerosis	4.82e-05	0.000512	CcSEcCtD
Omeprazole—Feeling abnormal—Triamcinolone—multiple sclerosis	4.82e-05	0.000512	CcSEcCtD
Omeprazole—Feeling abnormal—Methylprednisolone—multiple sclerosis	4.8e-05	0.00051	CcSEcCtD
Omeprazole—Anxiety—Prednisone—multiple sclerosis	4.8e-05	0.00051	CcSEcCtD
Omeprazole—Alopecia—Methotrexate—multiple sclerosis	4.8e-05	0.00051	CcSEcCtD
Omeprazole—Insomnia—Dexamethasone—multiple sclerosis	4.8e-05	0.000509	CcSEcCtD
Omeprazole—Insomnia—Betamethasone—multiple sclerosis	4.8e-05	0.000509	CcSEcCtD
Omeprazole—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	4.78e-05	0.000508	CcSEcCtD
Omeprazole—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	4.77e-05	0.000506	CcSEcCtD
Omeprazole—Paraesthesia—Betamethasone—multiple sclerosis	4.76e-05	0.000506	CcSEcCtD
Omeprazole—Paraesthesia—Dexamethasone—multiple sclerosis	4.76e-05	0.000506	CcSEcCtD
Omeprazole—Discomfort—Prednisone—multiple sclerosis	4.76e-05	0.000506	CcSEcCtD
Omeprazole—Mental disorder—Methotrexate—multiple sclerosis	4.76e-05	0.000506	CcSEcCtD
Omeprazole—Malnutrition—Methotrexate—multiple sclerosis	4.73e-05	0.000502	CcSEcCtD
Omeprazole—Hypersensitivity—Prednisolone—multiple sclerosis	4.68e-05	0.000497	CcSEcCtD
Omeprazole—Dyspepsia—Betamethasone—multiple sclerosis	4.67e-05	0.000496	CcSEcCtD
Omeprazole—Dyspepsia—Dexamethasone—multiple sclerosis	4.67e-05	0.000496	CcSEcCtD
Omeprazole—Urticaria—Triamcinolone—multiple sclerosis	4.64e-05	0.000493	CcSEcCtD
Omeprazole—Urticaria—Methylprednisolone—multiple sclerosis	4.63e-05	0.000492	CcSEcCtD
Omeprazole—Dysgeusia—Methotrexate—multiple sclerosis	4.63e-05	0.000492	CcSEcCtD
Omeprazole—Body temperature increased—Triamcinolone—multiple sclerosis	4.62e-05	0.000491	CcSEcCtD
Omeprazole—Anaphylactic shock—Prednisone—multiple sclerosis	4.62e-05	0.000491	CcSEcCtD
Omeprazole—Abdominal pain—Methylprednisolone—multiple sclerosis	4.61e-05	0.00049	CcSEcCtD
Omeprazole—Decreased appetite—Dexamethasone—multiple sclerosis	4.61e-05	0.00049	CcSEcCtD
Omeprazole—Decreased appetite—Betamethasone—multiple sclerosis	4.61e-05	0.00049	CcSEcCtD
Omeprazole—Nausea—Mitoxantrone—multiple sclerosis	4.6e-05	0.000489	CcSEcCtD
Omeprazole—Infection—Prednisone—multiple sclerosis	4.59e-05	0.000487	CcSEcCtD
Omeprazole—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	4.58e-05	0.000486	CcSEcCtD
Omeprazole—Gastrointestinal disorder—Betamethasone—multiple sclerosis	4.58e-05	0.000486	CcSEcCtD
Omeprazole—Back pain—Methotrexate—multiple sclerosis	4.57e-05	0.000486	CcSEcCtD
Omeprazole—Fatigue—Dexamethasone—multiple sclerosis	4.57e-05	0.000486	CcSEcCtD
Omeprazole—Fatigue—Betamethasone—multiple sclerosis	4.57e-05	0.000486	CcSEcCtD
Omeprazole—Shock—Prednisone—multiple sclerosis	4.54e-05	0.000483	CcSEcCtD
Omeprazole—Pain—Dexamethasone—multiple sclerosis	4.53e-05	0.000482	CcSEcCtD
Omeprazole—Pain—Betamethasone—multiple sclerosis	4.53e-05	0.000482	CcSEcCtD
Omeprazole—Nervous system disorder—Prednisone—multiple sclerosis	4.53e-05	0.000481	CcSEcCtD
Omeprazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	4.51e-05	0.00141	CbGpPWpGaD
Omeprazole—Tachycardia—Prednisone—multiple sclerosis	4.51e-05	0.000479	CcSEcCtD
Omeprazole—Skin disorder—Prednisone—multiple sclerosis	4.48e-05	0.000476	CcSEcCtD
Omeprazole—Hyperhidrosis—Prednisone—multiple sclerosis	4.46e-05	0.000474	CcSEcCtD
Omeprazole—Vision blurred—Methotrexate—multiple sclerosis	4.46e-05	0.000473	CcSEcCtD
Omeprazole—ABCG2—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	4.44e-05	0.00139	CbGpPWpGaD
Omeprazole—Anorexia—Prednisone—multiple sclerosis	4.4e-05	0.000468	CcSEcCtD
Omeprazole—Ill-defined disorder—Methotrexate—multiple sclerosis	4.39e-05	0.000466	CcSEcCtD
Omeprazole—CYP11A1—Biological oxidations—POMC—multiple sclerosis	4.38e-05	0.00137	CbGpPWpGaD
Omeprazole—Anaemia—Methotrexate—multiple sclerosis	4.37e-05	0.000464	CcSEcCtD
Omeprazole—Feeling abnormal—Dexamethasone—multiple sclerosis	4.37e-05	0.000464	CcSEcCtD
Omeprazole—Feeling abnormal—Betamethasone—multiple sclerosis	4.37e-05	0.000464	CcSEcCtD
Omeprazole—Gastrointestinal pain—Betamethasone—multiple sclerosis	4.34e-05	0.000461	CcSEcCtD
Omeprazole—Gastrointestinal pain—Dexamethasone—multiple sclerosis	4.34e-05	0.000461	CcSEcCtD
Omeprazole—CYP1B1—Aryl Hydrocarbon Receptor—TNF—multiple sclerosis	4.32e-05	0.00135	CbGpPWpGaD
Omeprazole—CYP1B1—Aryl Hydrocarbon Receptor Pathway—TNF—multiple sclerosis	4.32e-05	0.00135	CbGpPWpGaD
Omeprazole—Hypersensitivity—Triamcinolone—multiple sclerosis	4.31e-05	0.000457	CcSEcCtD
Omeprazole—Hypersensitivity—Methylprednisolone—multiple sclerosis	4.3e-05	0.000456	CcSEcCtD
Omeprazole—Malaise—Methotrexate—multiple sclerosis	4.26e-05	0.000453	CcSEcCtD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—RRM1—multiple sclerosis	4.26e-05	0.00133	CbGpPWpGaD
Omeprazole—Vertigo—Methotrexate—multiple sclerosis	4.25e-05	0.000451	CcSEcCtD
Omeprazole—Leukopenia—Methotrexate—multiple sclerosis	4.23e-05	0.00045	CcSEcCtD
Omeprazole—Urticaria—Dexamethasone—multiple sclerosis	4.21e-05	0.000447	CcSEcCtD
Omeprazole—Urticaria—Betamethasone—multiple sclerosis	4.21e-05	0.000447	CcSEcCtD
Omeprazole—Musculoskeletal discomfort—Prednisone—multiple sclerosis	4.21e-05	0.000447	CcSEcCtD
Omeprazole—Dizziness—Prednisolone—multiple sclerosis	4.2e-05	0.000446	CcSEcCtD
Omeprazole—Asthenia—Triamcinolone—multiple sclerosis	4.19e-05	0.000445	CcSEcCtD
Omeprazole—Body temperature increased—Dexamethasone—multiple sclerosis	4.19e-05	0.000445	CcSEcCtD
Omeprazole—Body temperature increased—Betamethasone—multiple sclerosis	4.19e-05	0.000445	CcSEcCtD
Omeprazole—Abdominal pain—Dexamethasone—multiple sclerosis	4.19e-05	0.000445	CcSEcCtD
Omeprazole—Abdominal pain—Betamethasone—multiple sclerosis	4.19e-05	0.000445	CcSEcCtD
Omeprazole—Asthenia—Methylprednisolone—multiple sclerosis	4.18e-05	0.000444	CcSEcCtD
Omeprazole—Insomnia—Prednisone—multiple sclerosis	4.18e-05	0.000444	CcSEcCtD
Omeprazole—CYP11A1—Corticotropin-releasing hormone—TGFB1—multiple sclerosis	4.17e-05	0.00131	CbGpPWpGaD
Omeprazole—Paraesthesia—Prednisone—multiple sclerosis	4.15e-05	0.00044	CcSEcCtD
Omeprazole—Pruritus—Triamcinolone—multiple sclerosis	4.13e-05	0.000439	CcSEcCtD
Omeprazole—Cough—Methotrexate—multiple sclerosis	4.13e-05	0.000438	CcSEcCtD
Omeprazole—Pruritus—Methylprednisolone—multiple sclerosis	4.12e-05	0.000438	CcSEcCtD
Omeprazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IFNG—multiple sclerosis	4.11e-05	0.00129	CbGpPWpGaD
Omeprazole—ABCB1—Allograft Rejection—HLA-DQA1—multiple sclerosis	4.1e-05	0.00128	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—SRM—multiple sclerosis	4.09e-05	0.00128	CbGpPWpGaD
Omeprazole—CYP11A1—Corticotropin-releasing hormone—MAPK1—multiple sclerosis	4.09e-05	0.00128	CbGpPWpGaD
Omeprazole—ATP4B—Transmembrane transport of small molecules—ALB—multiple sclerosis	4.07e-05	0.00127	CbGpPWpGaD
Omeprazole—Dyspepsia—Prednisone—multiple sclerosis	4.06e-05	0.000432	CcSEcCtD
Omeprazole—Chest pain—Methotrexate—multiple sclerosis	4.03e-05	0.000428	CcSEcCtD
Omeprazole—Myalgia—Methotrexate—multiple sclerosis	4.03e-05	0.000428	CcSEcCtD
Omeprazole—Arthralgia—Methotrexate—multiple sclerosis	4.03e-05	0.000428	CcSEcCtD
Omeprazole—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—multiple sclerosis	4.02e-05	0.00126	CbGpPWpGaD
Omeprazole—Decreased appetite—Prednisone—multiple sclerosis	4.01e-05	0.000426	CcSEcCtD
Omeprazole—Rash—Prednisolone—multiple sclerosis	4.01e-05	0.000426	CcSEcCtD
Omeprazole—Dermatitis—Prednisolone—multiple sclerosis	4e-05	0.000425	CcSEcCtD
Omeprazole—CYP1A1—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	4e-05	0.00125	CbGpPWpGaD
Omeprazole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	4e-05	0.000425	CcSEcCtD
Omeprazole—Diarrhoea—Methylprednisolone—multiple sclerosis	3.99e-05	0.000424	CcSEcCtD
Omeprazole—ABCC3—Metabolism—SRM—multiple sclerosis	3.98e-05	0.00125	CbGpPWpGaD
Omeprazole—Fatigue—Prednisone—multiple sclerosis	3.98e-05	0.000423	CcSEcCtD
Omeprazole—Headache—Prednisolone—multiple sclerosis	3.98e-05	0.000423	CcSEcCtD
Omeprazole—Discomfort—Methotrexate—multiple sclerosis	3.98e-05	0.000423	CcSEcCtD
Omeprazole—Constipation—Prednisone—multiple sclerosis	3.95e-05	0.000419	CcSEcCtD
Omeprazole—Confusional state—Methotrexate—multiple sclerosis	3.89e-05	0.000413	CcSEcCtD
Omeprazole—Dizziness—Triamcinolone—multiple sclerosis	3.86e-05	0.00041	CcSEcCtD
Omeprazole—Anaphylactic shock—Methotrexate—multiple sclerosis	3.86e-05	0.00041	CcSEcCtD
Omeprazole—ABCC3—Transmembrane transport of small molecules—AQP4—multiple sclerosis	3.86e-05	0.00121	CbGpPWpGaD
Omeprazole—Dizziness—Methylprednisolone—multiple sclerosis	3.86e-05	0.00041	CcSEcCtD
Omeprazole—ABCB1—Allograft Rejection—HLA-DQB1—multiple sclerosis	3.84e-05	0.0012	CbGpPWpGaD
Omeprazole—Infection—Methotrexate—multiple sclerosis	3.83e-05	0.000407	CcSEcCtD
Omeprazole—Feeling abnormal—Prednisone—multiple sclerosis	3.8e-05	0.000404	CcSEcCtD
Omeprazole—Asthenia—Betamethasone—multiple sclerosis	3.8e-05	0.000404	CcSEcCtD
Omeprazole—Asthenia—Dexamethasone—multiple sclerosis	3.8e-05	0.000404	CcSEcCtD
Omeprazole—CYP2C18—Biological oxidations—POMC—multiple sclerosis	3.79e-05	0.00119	CbGpPWpGaD
Omeprazole—Nervous system disorder—Methotrexate—multiple sclerosis	3.78e-05	0.000402	CcSEcCtD
Omeprazole—Thrombocytopenia—Methotrexate—multiple sclerosis	3.78e-05	0.000401	CcSEcCtD
Omeprazole—Gastrointestinal pain—Prednisone—multiple sclerosis	3.78e-05	0.000401	CcSEcCtD
Omeprazole—Nausea—Prednisolone—multiple sclerosis	3.77e-05	0.000401	CcSEcCtD
Omeprazole—CYP3A4—Biological oxidations—CYP24A1—multiple sclerosis	3.77e-05	0.00118	CbGpPWpGaD
Omeprazole—CYP3A4—Biological oxidations—CYP27B1—multiple sclerosis	3.77e-05	0.00118	CbGpPWpGaD
Omeprazole—Pruritus—Betamethasone—multiple sclerosis	3.75e-05	0.000398	CcSEcCtD
Omeprazole—Pruritus—Dexamethasone—multiple sclerosis	3.75e-05	0.000398	CcSEcCtD
Omeprazole—Skin disorder—Methotrexate—multiple sclerosis	3.75e-05	0.000398	CcSEcCtD
Omeprazole—Hyperhidrosis—Methotrexate—multiple sclerosis	3.73e-05	0.000396	CcSEcCtD
Omeprazole—Vomiting—Triamcinolone—multiple sclerosis	3.72e-05	0.000395	CcSEcCtD
Omeprazole—CYP3A4—Metapathway biotransformation—CYP27B1—multiple sclerosis	3.71e-05	0.00116	CbGpPWpGaD
Omeprazole—CYP3A4—Metapathway biotransformation—CYP24A1—multiple sclerosis	3.71e-05	0.00116	CbGpPWpGaD
Omeprazole—Vomiting—Methylprednisolone—multiple sclerosis	3.71e-05	0.000394	CcSEcCtD
Omeprazole—ABCB1—Allograft Rejection—CD86—multiple sclerosis	3.7e-05	0.00116	CbGpPWpGaD
Omeprazole—Rash—Triamcinolone—multiple sclerosis	3.68e-05	0.000391	CcSEcCtD
Omeprazole—Dermatitis—Triamcinolone—multiple sclerosis	3.68e-05	0.000391	CcSEcCtD
Omeprazole—Anorexia—Methotrexate—multiple sclerosis	3.68e-05	0.000391	CcSEcCtD
Omeprazole—Rash—Methylprednisolone—multiple sclerosis	3.68e-05	0.000391	CcSEcCtD
Omeprazole—Dermatitis—Methylprednisolone—multiple sclerosis	3.67e-05	0.00039	CcSEcCtD
Omeprazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL1B—multiple sclerosis	3.67e-05	0.00115	CbGpPWpGaD
Omeprazole—Urticaria—Prednisone—multiple sclerosis	3.67e-05	0.00039	CcSEcCtD
Omeprazole—CYP2C8—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	3.67e-05	0.00115	CbGpPWpGaD
Omeprazole—Headache—Triamcinolone—multiple sclerosis	3.66e-05	0.000389	CcSEcCtD
Omeprazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL2—multiple sclerosis	3.66e-05	0.00114	CbGpPWpGaD
Omeprazole—Headache—Methylprednisolone—multiple sclerosis	3.65e-05	0.000388	CcSEcCtD
Omeprazole—Body temperature increased—Prednisone—multiple sclerosis	3.65e-05	0.000388	CcSEcCtD
Omeprazole—Abdominal pain—Prednisone—multiple sclerosis	3.65e-05	0.000388	CcSEcCtD
Omeprazole—ATP4A—Transmembrane transport of small molecules—ALB—multiple sclerosis	3.63e-05	0.00114	CbGpPWpGaD
Omeprazole—Diarrhoea—Dexamethasone—multiple sclerosis	3.63e-05	0.000385	CcSEcCtD
Omeprazole—Diarrhoea—Betamethasone—multiple sclerosis	3.63e-05	0.000385	CcSEcCtD
Omeprazole—ABCB1—Allograft Rejection—IL10—multiple sclerosis	3.63e-05	0.00113	CbGpPWpGaD
Omeprazole—ABCB1—Allograft Rejection—CD40LG—multiple sclerosis	3.63e-05	0.00113	CbGpPWpGaD
Omeprazole—ABCB1—Allograft Rejection—IL4—multiple sclerosis	3.53e-05	0.0011	CbGpPWpGaD
Omeprazole—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	3.52e-05	0.000373	CcSEcCtD
Omeprazole—Dizziness—Betamethasone—multiple sclerosis	3.51e-05	0.000372	CcSEcCtD
Omeprazole—Dizziness—Dexamethasone—multiple sclerosis	3.51e-05	0.000372	CcSEcCtD
Omeprazole—Insomnia—Methotrexate—multiple sclerosis	3.49e-05	0.000371	CcSEcCtD
Omeprazole—Nausea—Triamcinolone—multiple sclerosis	3.47e-05	0.000369	CcSEcCtD
Omeprazole—Paraesthesia—Methotrexate—multiple sclerosis	3.46e-05	0.000368	CcSEcCtD
Omeprazole—Nausea—Methylprednisolone—multiple sclerosis	3.46e-05	0.000368	CcSEcCtD
Omeprazole—ABCB1—Allograft Rejection—HLA-B—multiple sclerosis	3.45e-05	0.00108	CbGpPWpGaD
Omeprazole—Dyspnoea—Methotrexate—multiple sclerosis	3.44e-05	0.000365	CcSEcCtD
Omeprazole—Somnolence—Methotrexate—multiple sclerosis	3.43e-05	0.000364	CcSEcCtD
Omeprazole—ABCC3—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	3.41e-05	0.00107	CbGpPWpGaD
Omeprazole—Hypersensitivity—Prednisone—multiple sclerosis	3.4e-05	0.000361	CcSEcCtD
Omeprazole—Dyspepsia—Methotrexate—multiple sclerosis	3.4e-05	0.000361	CcSEcCtD
Omeprazole—Vomiting—Dexamethasone—multiple sclerosis	3.37e-05	0.000358	CcSEcCtD
Omeprazole—Vomiting—Betamethasone—multiple sclerosis	3.37e-05	0.000358	CcSEcCtD
Omeprazole—ABCG2—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	3.37e-05	0.00105	CbGpPWpGaD
Omeprazole—Decreased appetite—Methotrexate—multiple sclerosis	3.35e-05	0.000356	CcSEcCtD
Omeprazole—Rash—Betamethasone—multiple sclerosis	3.34e-05	0.000355	CcSEcCtD
Omeprazole—Rash—Dexamethasone—multiple sclerosis	3.34e-05	0.000355	CcSEcCtD
Omeprazole—Dermatitis—Betamethasone—multiple sclerosis	3.34e-05	0.000355	CcSEcCtD
Omeprazole—Dermatitis—Dexamethasone—multiple sclerosis	3.34e-05	0.000355	CcSEcCtD
Omeprazole—CYP11A1—Metabolism—CYP27B1—multiple sclerosis	3.33e-05	0.00104	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism—CYP24A1—multiple sclerosis	3.33e-05	0.00104	CbGpPWpGaD
Omeprazole—Gastrointestinal disorder—Methotrexate—multiple sclerosis	3.33e-05	0.000354	CcSEcCtD
Omeprazole—Fatigue—Methotrexate—multiple sclerosis	3.33e-05	0.000353	CcSEcCtD
Omeprazole—Headache—Dexamethasone—multiple sclerosis	3.32e-05	0.000353	CcSEcCtD
Omeprazole—Headache—Betamethasone—multiple sclerosis	3.32e-05	0.000353	CcSEcCtD
Omeprazole—Asthenia—Prednisone—multiple sclerosis	3.31e-05	0.000352	CcSEcCtD
Omeprazole—Pain—Methotrexate—multiple sclerosis	3.3e-05	0.000351	CcSEcCtD
Omeprazole—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	3.27e-05	0.00102	CbGpPWpGaD
Omeprazole—Pruritus—Prednisone—multiple sclerosis	3.27e-05	0.000347	CcSEcCtD
Omeprazole—CYP11A1—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	3.26e-05	0.00102	CbGpPWpGaD
Omeprazole—ABCB1—Allograft Rejection—FAS—multiple sclerosis	3.25e-05	0.00102	CbGpPWpGaD
Omeprazole—CYP1A1—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	3.24e-05	0.00101	CbGpPWpGaD
Omeprazole—ABCB1—Allograft Rejection—IL2RA—multiple sclerosis	3.23e-05	0.00101	CbGpPWpGaD
Omeprazole—ABCB1—Allograft Rejection—HLA-A—multiple sclerosis	3.2e-05	0.001	CbGpPWpGaD
Omeprazole—Feeling abnormal—Methotrexate—multiple sclerosis	3.18e-05	0.000338	CcSEcCtD
Omeprazole—Diarrhoea—Prednisone—multiple sclerosis	3.16e-05	0.000336	CcSEcCtD
Omeprazole—Gastrointestinal pain—Methotrexate—multiple sclerosis	3.16e-05	0.000335	CcSEcCtD
Omeprazole—Nausea—Betamethasone—multiple sclerosis	3.15e-05	0.000335	CcSEcCtD
Omeprazole—Nausea—Dexamethasone—multiple sclerosis	3.15e-05	0.000335	CcSEcCtD
Omeprazole—Urticaria—Methotrexate—multiple sclerosis	3.07e-05	0.000326	CcSEcCtD
Omeprazole—Dizziness—Prednisone—multiple sclerosis	3.05e-05	0.000324	CcSEcCtD
Omeprazole—Abdominal pain—Methotrexate—multiple sclerosis	3.05e-05	0.000324	CcSEcCtD
Omeprazole—Body temperature increased—Methotrexate—multiple sclerosis	3.05e-05	0.000324	CcSEcCtD
Omeprazole—CYP11A1—Metabolism—GPC5—multiple sclerosis	3.05e-05	0.000954	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—SRM—multiple sclerosis	3.02e-05	0.000944	CbGpPWpGaD
Omeprazole—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	3.01e-05	0.000942	CbGpPWpGaD
Omeprazole—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	2.98e-05	0.000934	CbGpPWpGaD
Omeprazole—CYP2C8—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	2.97e-05	0.00093	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	2.94e-05	0.00092	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	2.94e-05	0.00092	CbGpPWpGaD
Omeprazole—Vomiting—Prednisone—multiple sclerosis	2.94e-05	0.000312	CcSEcCtD
Omeprazole—ABCB1—Allograft Rejection—HLA-DRB1—multiple sclerosis	2.92e-05	0.000914	CbGpPWpGaD
Omeprazole—Rash—Prednisone—multiple sclerosis	2.91e-05	0.000309	CcSEcCtD
Omeprazole—Dermatitis—Prednisone—multiple sclerosis	2.91e-05	0.000309	CcSEcCtD
Omeprazole—Headache—Prednisone—multiple sclerosis	2.89e-05	0.000307	CcSEcCtD
Omeprazole—CYP2C18—Metabolism—CYP27B1—multiple sclerosis	2.88e-05	0.000903	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—CYP24A1—multiple sclerosis	2.88e-05	0.000903	CbGpPWpGaD
Omeprazole—CYP1A1—Aryl Hydrocarbon Receptor—MYC—multiple sclerosis	2.86e-05	0.000895	CbGpPWpGaD
Omeprazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—multiple sclerosis	2.85e-05	0.000893	CbGpPWpGaD
Omeprazole—Hypersensitivity—Methotrexate—multiple sclerosis	2.84e-05	0.000302	CcSEcCtD
Omeprazole—ABCC3—Metabolism—CYP27B1—multiple sclerosis	2.8e-05	0.000878	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—CYP24A1—multiple sclerosis	2.8e-05	0.000878	CbGpPWpGaD
Omeprazole—CYP1A1—Aryl Hydrocarbon Receptor—MAPK1—multiple sclerosis	2.8e-05	0.000875	CbGpPWpGaD
Omeprazole—CYP1B1—Biological oxidations—POMC—multiple sclerosis	2.8e-05	0.000875	CbGpPWpGaD
Omeprazole—Asthenia—Methotrexate—multiple sclerosis	2.77e-05	0.000294	CcSEcCtD
Omeprazole—ABCG2—Metabolism—SRM—multiple sclerosis	2.74e-05	0.000859	CbGpPWpGaD
Omeprazole—Nausea—Prednisone—multiple sclerosis	2.74e-05	0.000291	CcSEcCtD
Omeprazole—ABCC3—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	2.74e-05	0.000858	CbGpPWpGaD
Omeprazole—Pruritus—Methotrexate—multiple sclerosis	2.73e-05	0.00029	CcSEcCtD
Omeprazole—ABCB1—Allograft Rejection—CD80—multiple sclerosis	2.7e-05	0.000844	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	2.69e-05	0.000844	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	2.69e-05	0.000844	CbGpPWpGaD
Omeprazole—CYP1A1—Aryl Hydrocarbon Receptor—TNF—multiple sclerosis	2.66e-05	0.000834	CbGpPWpGaD
Omeprazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—multiple sclerosis	2.66e-05	0.000834	CbGpPWpGaD
Omeprazole—ABCG2—Transmembrane transport of small molecules—AQP4—multiple sclerosis	2.66e-05	0.000833	CbGpPWpGaD
Omeprazole—CYP2C19—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	2.65e-05	0.00083	CbGpPWpGaD
Omeprazole—Diarrhoea—Methotrexate—multiple sclerosis	2.64e-05	0.00028	CcSEcCtD
Omeprazole—CYP2C18—Metabolism—GPC5—multiple sclerosis	2.64e-05	0.000825	CbGpPWpGaD
Omeprazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—multiple sclerosis	2.62e-05	0.000821	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—GPC5—multiple sclerosis	2.57e-05	0.000803	CbGpPWpGaD
Omeprazole—Dizziness—Methotrexate—multiple sclerosis	2.55e-05	0.000271	CcSEcCtD
Omeprazole—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	2.55e-05	0.000798	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism—RRM1—multiple sclerosis	2.53e-05	0.00079	CbGpPWpGaD
Omeprazole—Vomiting—Methotrexate—multiple sclerosis	2.45e-05	0.000261	CcSEcCtD
Omeprazole—CYP2D6—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	2.44e-05	0.000764	CbGpPWpGaD
Omeprazole—Rash—Methotrexate—multiple sclerosis	2.43e-05	0.000258	CcSEcCtD
Omeprazole—Dermatitis—Methotrexate—multiple sclerosis	2.43e-05	0.000258	CcSEcCtD
Omeprazole—ABCC3—NRF2 pathway—TGFB1—multiple sclerosis	2.43e-05	0.000759	CbGpPWpGaD
Omeprazole—CYP2C9—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	2.42e-05	0.000757	CbGpPWpGaD
Omeprazole—Headache—Methotrexate—multiple sclerosis	2.42e-05	0.000257	CcSEcCtD
Omeprazole—CYP2C19—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	2.41e-05	0.000753	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	2.41e-05	0.000753	CbGpPWpGaD
Omeprazole—ABCB1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	2.4e-05	0.000752	CbGpPWpGaD
Omeprazole—ABCG2—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	2.35e-05	0.000736	CbGpPWpGaD
Omeprazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—multiple sclerosis	2.34e-05	0.000732	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—TNFRSF1A—multiple sclerosis	2.33e-05	0.000731	CbGpPWpGaD
Omeprazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—multiple sclerosis	2.33e-05	0.00073	CbGpPWpGaD
Omeprazole—Nausea—Methotrexate—multiple sclerosis	2.29e-05	0.000244	CcSEcCtD
Omeprazole—CYP2C9—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	2.19e-05	0.000687	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	2.19e-05	0.000687	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—RRM1—multiple sclerosis	2.19e-05	0.000684	CbGpPWpGaD
Omeprazole—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—multiple sclerosis	2.17e-05	0.00068	CbGpPWpGaD
Omeprazole—ABCB1—Allograft Rejection—IFNG—multiple sclerosis	2.13e-05	0.000667	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—RRM1—multiple sclerosis	2.13e-05	0.000665	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—CYP24A1—multiple sclerosis	2.13e-05	0.000665	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—CYP27B1—multiple sclerosis	2.13e-05	0.000665	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	2.08e-05	0.00065	CbGpPWpGaD
Omeprazole—CYP1A2—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	2.07e-05	0.000647	CbGpPWpGaD
Omeprazole—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	1.97e-05	0.000616	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.96e-05	0.000613	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—GPC5—multiple sclerosis	1.94e-05	0.000609	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—CYP27B1—multiple sclerosis	1.93e-05	0.000605	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—CYP24A1—multiple sclerosis	1.93e-05	0.000605	CbGpPWpGaD
Omeprazole—ABCB1—Allograft Rejection—IL1B—multiple sclerosis	1.9e-05	0.000595	CbGpPWpGaD
Omeprazole—ABCB1—Allograft Rejection—IL2—multiple sclerosis	1.89e-05	0.000593	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	1.87e-05	0.000587	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	1.87e-05	0.000587	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	1.87e-05	0.000587	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—SRM—multiple sclerosis	1.86e-05	0.000582	CbGpPWpGaD
Omeprazole—CYP1A2—Aryl Hydrocarbon Receptor—MYC—multiple sclerosis	1.82e-05	0.000571	CbGpPWpGaD
Omeprazole—ABCB1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	1.82e-05	0.00057	CbGpPWpGaD
Omeprazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—multiple sclerosis	1.82e-05	0.000569	CbGpPWpGaD
Omeprazole—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—multiple sclerosis	1.78e-05	0.000558	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—GPC5—multiple sclerosis	1.77e-05	0.000554	CbGpPWpGaD
Omeprazole—CYP1A1—Biological oxidations—POMC—multiple sclerosis	1.72e-05	0.000539	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—SRM—multiple sclerosis	1.7e-05	0.000533	CbGpPWpGaD
Omeprazole—CYP1A2—Aryl Hydrocarbon Receptor—TNF—multiple sclerosis	1.7e-05	0.000532	CbGpPWpGaD
Omeprazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—multiple sclerosis	1.7e-05	0.000532	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.68e-05	0.000527	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.65e-05	0.000516	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—RRM1—multiple sclerosis	1.61e-05	0.000504	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	1.6e-05	0.000502	CbGpPWpGaD
Omeprazole—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	1.6e-05	0.000499	CbGpPWpGaD
Omeprazole—CYP2C8—Biological oxidations—POMC—multiple sclerosis	1.58e-05	0.000494	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.53e-05	0.00048	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—SRM—multiple sclerosis	1.52e-05	0.000476	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—SRM—multiple sclerosis	1.48e-05	0.000465	CbGpPWpGaD
Omeprazole—ABCB1—Allograft Rejection—TGFB1—multiple sclerosis	1.48e-05	0.000463	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—RRM1—multiple sclerosis	1.47e-05	0.000459	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism—BCHE—multiple sclerosis	1.45e-05	0.000454	CbGpPWpGaD
Omeprazole—ABCB1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	1.44e-05	0.00045	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.42e-05	0.000443	CbGpPWpGaD
Omeprazole—CYP2C19—Biological oxidations—POMC—multiple sclerosis	1.41e-05	0.000441	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—SRM—multiple sclerosis	1.4e-05	0.000438	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—SRM—multiple sclerosis	1.39e-05	0.000434	CbGpPWpGaD
Omeprazole—ABCB1—Allograft Rejection—TNF—multiple sclerosis	1.38e-05	0.000432	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—CYP27B1—multiple sclerosis	1.31e-05	0.00041	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—CYP24A1—multiple sclerosis	1.31e-05	0.00041	CbGpPWpGaD
Omeprazole—CYP2D6—Biological oxidations—POMC—multiple sclerosis	1.3e-05	0.000406	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.29e-05	0.000404	CbGpPWpGaD
Omeprazole—CYP2C9—Biological oxidations—POMC—multiple sclerosis	1.28e-05	0.000402	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	1.28e-05	0.0004	CbGpPWpGaD
Omeprazole—ABCB1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	1.27e-05	0.000398	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—BCHE—multiple sclerosis	1.25e-05	0.000393	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.25e-05	0.000391	CbGpPWpGaD
Omeprazole—ABCC3—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.23e-05	0.000384	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—BCHE—multiple sclerosis	1.22e-05	0.000382	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—CYP24A1—multiple sclerosis	1.2e-05	0.000376	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—CYP27B1—multiple sclerosis	1.2e-05	0.000376	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—GPC5—multiple sclerosis	1.2e-05	0.000375	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—SRM—multiple sclerosis	1.18e-05	0.000371	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	1.17e-05	0.000367	CbGpPWpGaD
Omeprazole—CYP1A2—Biological oxidations—POMC—multiple sclerosis	1.1e-05	0.000344	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—GPC5—multiple sclerosis	1.1e-05	0.000344	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.07e-05	0.000336	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—CYP27B1—multiple sclerosis	1.07e-05	0.000335	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—CYP24A1—multiple sclerosis	1.07e-05	0.000335	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	1.05e-05	0.000328	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—CYP27B1—multiple sclerosis	1.05e-05	0.000327	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—CYP24A1—multiple sclerosis	1.05e-05	0.000327	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—RRM1—multiple sclerosis	9.92e-06	0.000311	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—CYP24A1—multiple sclerosis	9.85e-06	0.000308	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—CYP27B1—multiple sclerosis	9.85e-06	0.000308	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—GPC5—multiple sclerosis	9.8e-06	0.000307	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	9.79e-06	0.000306	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—CYP27B1—multiple sclerosis	9.77e-06	0.000306	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—CYP24A1—multiple sclerosis	9.77e-06	0.000306	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—GPC5—multiple sclerosis	9.56e-06	0.000299	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	9.55e-06	0.000299	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—BCHE—multiple sclerosis	9.25e-06	0.00029	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—SRM—multiple sclerosis	9.14e-06	0.000286	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—RRM1—multiple sclerosis	9.09e-06	0.000285	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—GPC5—multiple sclerosis	9.01e-06	0.000282	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—GPC5—multiple sclerosis	8.93e-06	0.00028	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism—APOE—multiple sclerosis	8.73e-06	0.000273	CbGpPWpGaD
Omeprazole—CYP3A4—Biological oxidations—POMC—multiple sclerosis	8.47e-06	0.000265	CbGpPWpGaD
Omeprazole—ABCG2—Transmembrane transport of small molecules—ALB—multiple sclerosis	8.47e-06	0.000265	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—BCHE—multiple sclerosis	8.42e-06	0.000263	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—CYP27B1—multiple sclerosis	8.35e-06	0.000261	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—CYP24A1—multiple sclerosis	8.35e-06	0.000261	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	8.16e-06	0.000255	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—RRM1—multiple sclerosis	8.12e-06	0.000254	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—RRM1—multiple sclerosis	7.92e-06	0.000248	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	7.7e-06	0.000241	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—GPC5—multiple sclerosis	7.63e-06	0.000239	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—APOE—multiple sclerosis	7.55e-06	0.000236	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism—POMC—multiple sclerosis	7.5e-06	0.000235	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—RRM1—multiple sclerosis	7.47e-06	0.000234	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—RRM1—multiple sclerosis	7.4e-06	0.000232	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—APOE—multiple sclerosis	7.34e-06	0.00023	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	7.31e-06	0.000229	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	7.29e-06	0.000228	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	7.15e-06	0.000224	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	7.06e-06	0.000221	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism—ALB—multiple sclerosis	6.83e-06	0.000214	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	6.81e-06	0.000213	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	6.61e-06	0.000207	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—POMC—multiple sclerosis	6.49e-06	0.000203	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	6.44e-06	0.000202	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	6.44e-06	0.000202	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—RRM1—multiple sclerosis	6.33e-06	0.000198	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—POMC—multiple sclerosis	6.31e-06	0.000197	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	6.3e-06	0.000197	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	6.06e-06	0.00019	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	6.03e-06	0.000189	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—ALB—multiple sclerosis	5.91e-06	0.000185	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—GPC5—multiple sclerosis	5.89e-06	0.000184	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—ALB—multiple sclerosis	5.75e-06	0.00018	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	5.74e-06	0.00018	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—BCHE—multiple sclerosis	5.7e-06	0.000178	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—APOE—multiple sclerosis	5.57e-06	0.000174	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	5.53e-06	0.000173	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	5.41e-06	0.000169	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—BCHE—multiple sclerosis	5.22e-06	0.000164	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—APOE—multiple sclerosis	5.06e-06	0.000159	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	4.93e-06	0.000154	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	4.93e-06	0.000154	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	4.91e-06	0.000154	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—RRM1—multiple sclerosis	4.88e-06	0.000153	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—POMC—multiple sclerosis	4.78e-06	0.00015	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—BCHE—multiple sclerosis	4.66e-06	0.000146	CbGpPWpGaD
Omeprazole—ABCB1—Transmembrane transport of small molecules—ALB—multiple sclerosis	4.58e-06	0.000143	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—BCHE—multiple sclerosis	4.55e-06	0.000142	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	4.5e-06	0.000141	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—ALB—multiple sclerosis	4.36e-06	0.000136	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—POMC—multiple sclerosis	4.35e-06	0.000136	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—BCHE—multiple sclerosis	4.29e-06	0.000134	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—BCHE—multiple sclerosis	4.25e-06	0.000133	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	4.22e-06	0.000132	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—ALB—multiple sclerosis	3.97e-06	0.000124	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	3.84e-06	0.00012	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—BCHE—multiple sclerosis	3.63e-06	0.000114	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—APOE—multiple sclerosis	3.43e-06	0.000107	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—APOE—multiple sclerosis	3.14e-06	9.84e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—POMC—multiple sclerosis	2.94e-06	9.22e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—APOE—multiple sclerosis	2.8e-06	8.78e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—BCHE—multiple sclerosis	2.8e-06	8.78e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—APOE—multiple sclerosis	2.74e-06	8.57e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—POMC—multiple sclerosis	2.7e-06	8.45e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—ALB—multiple sclerosis	2.68e-06	8.4e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—APOE—multiple sclerosis	2.58e-06	8.08e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—APOE—multiple sclerosis	2.56e-06	8.01e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—ALB—multiple sclerosis	2.46e-06	7.7e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—POMC—multiple sclerosis	2.41e-06	7.54e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—POMC—multiple sclerosis	2.35e-06	7.36e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—POMC—multiple sclerosis	2.22e-06	6.94e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—POMC—multiple sclerosis	2.2e-06	6.88e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—ALB—multiple sclerosis	2.2e-06	6.88e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—APOE—multiple sclerosis	2.19e-06	6.84e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—ALB—multiple sclerosis	2.14e-06	6.71e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—ALB—multiple sclerosis	2.02e-06	6.32e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—ALB—multiple sclerosis	2e-06	6.27e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—POMC—multiple sclerosis	1.88e-06	5.88e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—ALB—multiple sclerosis	1.71e-06	5.36e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—APOE—multiple sclerosis	1.69e-06	5.28e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—POMC—multiple sclerosis	1.45e-06	4.54e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—ALB—multiple sclerosis	1.32e-06	4.14e-05	CbGpPWpGaD
